Suppr超能文献

在伴有早发型胎儿生长受限的单胎妊娠中 sFlt-1/PlGF 比值的纵向变化。

Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.

机构信息

Fetal Medicine Unit-SAMID, Department of Obstetrics and Gynaecology, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.

出版信息

Ultrasound Obstet Gynecol. 2018 Nov;52(5):631-638. doi: 10.1002/uog.18894.

Abstract

OBJECTIVE

To describe the evolution of soluble fms-like tyrosine kinase-1 to placental growth factor (sFlt-1/PlGF) ratio in the last 5 weeks prior to delivery in singleton pregnancy complicated by early-onset fetal growth restriction (FGR), with or without pre-eclampsia (PE).

METHODS

This was a prospective observational cohort study of early-onset FGR cases that underwent serial assessment of maternal serum sFlt-1/PlGF ratio from diagnosis to delivery. Measurements were made at weekly intervals and within the last 48 h before birth. Absolute values and percentage increase between time intervals were computed, and previously described cut-off values of 38 (suspicion of PE), 85 (aids diagnosis of PE) and 655 (high risk for imminent delivery) were used for analysis of the sFlt-1/PlGF ratio. We compared findings between cases with early-onset FGR only (n = 37) and those that additionally developed PE (n = 36).

RESULTS

Overall perinatal survival was 63/73 (86.3%). A sFlt-1/PlGF ratio above 38 was observed 4 weeks before delivery in most FGR-only and FGR with PE cases (73% and 100%, respectively), but absolute values of sFlt-1/PlGF were significantly higher in FGR cases with PE. Extremely elevated values of the ratio (≥ 655) within the last 48 h before delivery were found in 65% of cases of FGR with PE, but in only 8% of isolated FGR cases (P < 0.001).

CONCLUSION

Elevated sFlt-1/PlGF was observed in most early-onset FGR pregnancies from 4 weeks before delivery, and values were even higher if there was concurrent PE. However, serial measurements of the ratio were of limited value, being useful only to anticipate the need for imminent delivery in cases of FGR with PE when sFlt-1/PlGF values ≥ 655 were reached. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

摘要

目的

描述在伴有或不伴有子痫前期(PE)的早发型胎儿生长受限(FGR)单胎妊娠分娩前 5 周内可溶性 fms 样酪氨酸激酶-1 至胎盘生长因子(sFlt-1/PlGF)比值的变化。

方法

这是一项早发型 FGR 病例的前瞻性观察队列研究,对这些病例进行了从诊断到分娩的连续母体血清 sFlt-1/PlGF 比值评估。测量间隔为每周一次,分娩前 48 小时内进行一次。计算时间间隔之间的绝对值和百分比增加,并使用之前描述的 38(疑似 PE)、85(辅助诊断 PE)和 655(即将分娩高风险)的 cut-off 值分析 sFlt-1/PlGF 比值。我们比较了仅有早发型 FGR 病例(n=37)和另外发生 PE 的病例(n=36)之间的结果。

结果

总体围产儿存活率为 63/73(86.3%)。大多数仅有 FGR 和 FGR 伴 PE 的病例在分娩前 4 周观察到 sFlt-1/PlGF 比值高于 38(分别为 73%和 100%),但 FGR 伴 PE 病例的 sFlt-1/PlGF 绝对值明显更高。在分娩前 48 小时内,FGR 伴 PE 的病例中发现比值(≥655)极高的比例为 65%,而仅有 FGR 的病例中仅为 8%(P<0.001)。

结论

从分娩前 4 周开始,大多数早发型 FGR 妊娠中均可观察到升高的 sFlt-1/PlGF,而如果同时发生 PE,则值更高。然而,比值的连续测量价值有限,只有当达到 sFlt-1/PlGF 值≥655 时,才对预测 FGR 伴 PE 病例的即将分娩有用。版权所有©2017 ISUOG。由 John Wiley & Sons Ltd 出版。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验